Yeatts, J. P., Kiser, M. M., Goss, C. H., Schechter, M. S., Konstan, M. W., Pace, R. G., … Knowles, M. R. (2007). Early clinical features of Delta F508 homozygotes defined as "severe" or "mild" for the gene modifier study of CF lung disease. In PEDIATRIC PULMONOLOGY (pp. 273–273). WILEY-LISS.

Yeatts, J. P., M. M. Kiser, C. H. Goss, M. S. Schechter, M. W. Konstan, R. G. Pace, F. A. Wright, M. L. Drumm, and M. R. Knowles. “Early clinical features of Delta F508 homozygotes defined as "severe" or "mild" for the gene modifier study of CF lung disease.” In PEDIATRIC PULMONOLOGY, 273–273. WILEY-LISS, 2007.

Yeatts JP, Kiser MM, Goss CH, Schechter MS, Konstan MW, Pace RG, et al. Early clinical features of Delta F508 homozygotes defined as "severe" or "mild" for the gene modifier study of CF lung disease. In: PEDIATRIC PULMONOLOGY. WILEY-LISS; 2007. p. 273–273.

Yeatts, J. P., et al. “Early clinical features of Delta F508 homozygotes defined as "severe" or "mild" for the gene modifier study of CF lung disease.” PEDIATRIC PULMONOLOGY, WILEY-LISS, 2007, pp. 273–273.

Yeatts JP, Kiser MM, Goss CH, Schechter MS, Konstan MW, Pace RG, Wright FA, Drumm ML, Knowles MR. Early clinical features of Delta F508 homozygotes defined as "severe" or "mild" for the gene modifier study of CF lung disease. PEDIATRIC PULMONOLOGY. WILEY-LISS; 2007. p. 273–273.